Effectiveness of BNT162b2 BA.4/5 bivalent mRNA vaccine against a range of COVID-19 outcomes in a large health system in the USA: a test-negative case-control study

Tartof, SY; Slezak, JM; Puzniak, L; Hong, VN; Frankland, TB; Ackerson, BK; Xie, FG; Takhar, H; Ogun, OA; Simmons, S; Zamparo, JM; Valluri, SR; Jodar, L; Mclaughlin, JM

Tartof, SY (通讯作者),Kaiser Permanente Southern Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA.

LANCET RESPIRATORY MEDICINE, 2023; 11 (12): 1089

Abstract

Background XBB-related omicron sublineages have recently replaced BA.4/5 as the predominant omicron sublineages in the USA and other regions globally.......

Full Text Link